Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov 7;103(45):16942-7.
doi: 10.1073/pnas.0606863103. Epub 2006 Oct 30.

Vaccine assembly from surface proteins of Staphylococcus aureus

Affiliations

Vaccine assembly from surface proteins of Staphylococcus aureus

Yukiko K Stranger-Jones et al. Proc Natl Acad Sci U S A. .

Abstract

Staphylococcus aureus is the most common cause of hospital-acquired infection. Because of the emergence of antibiotic-resistant strains, these infections represent a serious public health threat. To develop a broadly protective vaccine, we tested cell wall-anchored surface proteins of S. aureus as antigens in a murine model of abscess formation. Immunization with four antigens (IsdA, IsdB, SdrD, and SdrE) generated significant protective immunity that correlated with the induction of opsonophagocytic antibodies. When assembled into a combined vaccine, the four surface proteins afforded high levels of protection against invasive disease or lethal challenge with human clinical S. aureus isolates.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Antibodies against IsdA, IsdB, SdrD, and SdrE mediate complement-dependent opsonophagocytosis. Phagocytic assays were performed to determine the mechanism of protection afforded by surface-protein immunizations. Rabbit antibodies, rabbit complement, freshly isolated human PMNs, and S. aureus were incubated and plated on agar medium to measure bacterial survival as cfu; then the percent of killing was calculated. Antibodies were added either as individual antisera raised against one surface protein (α-IsdA, α-IsdB, α-SdrD, or α-SdrE) or as a mixture of antisera (α-IsdA + α-IsdB + α-SdrD + α-SdrE) to PMNs. Opsonsonophagocytic killing of staphylococci in the presence of complement was significantly increased for mixed antisera compared with individual surface-protein antisera (P < 0.03). Error bars represent the SEM.
Fig. 2.
Fig. 2.
Immunization with the combined vaccine (IsdA, IsdB, SdrD, and SdrE) generates protective immunity against S. aureus abscess formation in mice. BALB/c mice were mock-immunized (A and B) or immunized with the combined vaccine (C and D) and challenged by retroorbital infection with S. aureus Newman. Four days after infection, animals were killed, and the kidneys were removed. Organ tissue was fixed in formalin, thin-sectioned, and stained with hematoxylin/eosin. Microscopic images of whole kidneys (A and C) or organ tissue at higher magnification (B and D) revealed abscess formation only in mock-immunized animals. Similar results were obtained for six organ tissues in each group. (Scale bars: A and C, 1 mm; B and D, 0.1 mm.) (B) Staphylococcal abscess (black arrow) with a central concentration of staphylococci (white arrow). (D) PMN infiltrate (black arrow).
Fig. 3.
Fig. 3.
Immunization with the combined vaccine (IsdA, IsdB, SdrD, and SdrE) generates protective immunity against lethal S. aureus challenge. Mice (n = 8–10) were immunized with individual surface-protein antigens (IsdA, IsdB, SdrD, or SdrE), with the combined vaccine (IsdA, IsdB, SdrD, and SdrE) or with PBS. Animals were challenged by intraperitoneal injection of S. aureus Newman (2 × 1010 cfu), and then they were monitored for 7 days. Compared with animals receiving mock-immunization (PBS), the significance of protective immunity generated by various antigens was measured with Fisher's exact test: IsdA, P = 0.34372; IsdB, P = 0.22049; SdrD, P = 0.24006; SdrE, P = 0.31508; and combined vaccine, P = 0.02941. Compared with animals receiving the combined vaccine, the significance of protective immunity was measured with Fisher's exact test: PBS, P = 0.02941; IsdA, P = 0.02941; IsdB, P = 0.05294; SdrD, P = 0.00377; and SdrE, P = 0.01131.
Fig. 4.
Fig. 4.
Immunization with the combined vaccine generates protective immunity against lethal challenge with five different clinical S. aureus isolates. Mice (n = 10) were immunized with the combined vaccine (IsdA, IsdB, SdrD, and SdrE) or with PBS, challenged by intraperitoneal injection with clinical S. aureus isolates (3–10 × 109 cfu), and monitored for 7 days for survival. Compared with animals receiving mock-immunization (PBS), the significance of protective immunity generated by the combined vaccine was measured with Fisher's exact test: (A) N315, P = 0.06502; (B) NRS248, P = 0.00036; (C) NRS252, P = 0.03215; (D) USA100, P = 0.00542; and (E) USA400, P = 0.00542.

References

    1. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M. Clin Infect Dis. 2001;32:S114–S132. - PubMed
    1. Lowy FD. N Engl J Med. 1998;339:520–532. - PubMed
    1. Archer GL, Climo MW. N Engl J Med. 2001;344:55–56. - PubMed
    1. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, Mason EOJ. Clin Infect Dis. 2005;40:1785–1791. - PubMed
    1. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. Science. 2003;302:1569–1571. - PubMed

Publication types

MeSH terms